RALLYBIO CORPORATION Payments to Acquire Interest in Joint Venture
RALLYBIO CORPORATION (RLYB) reported Payments to Acquire Interest in Joint Venture of $0 for the 6-month period ending 2026-06-30, per its S-4/A filed 2026-08-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2026-08-26
- RALLYBIO CORPORATION payments to acquire interest in joint venture for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for the quarter ending 2025-12-31 was $0.00.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for fiscal 2023 was $2.25M, a 650.00% increase from fiscal 2022.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for fiscal 2022 was $300.00K, a 85.00% decline from fiscal 2021.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for fiscal 2021 was $2.00M, a 3.36% increase from fiscal 2020.
- RALLYBIO CORPORATION payments to acquire interest in joint venture for fiscal 2020 was $1.94M.
| Period end | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: S-4/A 6 month − S-4 3 month · filed 2026-08-26 | $0.00 S-4/A · filed 2026-08-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-26 | $0.00 derived: sum of 4 quarters · filed 2026-08-26 |
| 2026-03-31 | $0.00 S-4 · filed 2026-07-15 | $0.00 derived: sum of 2 quarters · filed 2026-08-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-26 | $500.00K derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | $0.00 derived: sum of 2 quarters · filed 2026-08-26 | $500.00K derived: sum of 3 quarters · filed 2026-08-26 | $1.50M S-4/A · filed 2026-08-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-4/A 6 month · filed 2025-11-06 | $500.00K derived: sum of 2 quarters · filed 2026-08-26 | $1.50M 10-Q · filed 2025-11-06 | $1.50M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-06-30 | $500.00K derived: S-4/A 6 month − S-4 3 month · filed 2026-08-26 | $1.50M S-4/A · filed 2026-08-26 | $1.50M derived: sum of 3 quarters · filed 2026-08-26 | $2.00M derived: sum of 4 quarters · filed 2026-08-26 |
| 2025-03-31 | $1.00M S-4 · filed 2026-07-15 | $1.00M derived: sum of 2 quarters · filed 2026-08-26 | $1.50M derived: sum of 3 quarters · filed 2026-08-26 | $2.25M derived: sum of 4 quarters · filed 2026-08-26 |
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-08-26 | $500.00K derived: sum of 2 quarters · filed 2026-08-26 | $1.25M derived: sum of 3 quarters · filed 2026-08-26 | $2.00M S-4/A · filed 2026-08-26 |
| 2024-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.25M derived: sum of 2 quarters · filed 2025-11-06 | $2.00M 10-Q · filed 2025-11-06 | $2.75M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.50M 10-Q · filed 2025-08-07 | $2.25M derived: sum of 3 quarters · filed 2025-08-07 | $3.00M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $750.00K 10-Q · filed 2025-05-08 | $1.50M derived: sum of 2 quarters · filed 2025-05-08 | $2.25M derived: sum of 3 quarters · filed 2025-05-08 | $2.25M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $1.50M derived: sum of 2 quarters · filed 2025-03-13 | $1.50M derived: sum of 3 quarters · filed 2025-03-13 | $2.25M 10-K · filed 2025-03-13 |
| 2023-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $750.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.50M 10-Q · filed 2024-11-07 | $1.50M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $750.00K 10-Q · filed 2024-08-08 | $750.00K derived: sum of 3 quarters · filed 2024-08-08 | $900.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $750.00K 10-Q · filed 2024-05-09 | $750.00K derived: sum of 2 quarters · filed 2024-05-09 | $900.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.05M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $150.00K derived: sum of 2 quarters · filed 2024-03-12 | $300.00K derived: sum of 3 quarters · filed 2024-03-12 | $300.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $300.00K derived: sum of 2 quarters · filed 2023-11-09 | $300.00K 10-Q · filed 2023-11-09 | $300.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $150.00K 10-Q · filed 2023-08-08 | $150.00K derived: sum of 3 quarters · filed 2023-08-08 | $150.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-05-09 | $0.00 derived: sum of 3 quarters · filed 2023-05-09 | $1.50M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-03-06 | $1.50M derived: sum of 3 quarters · filed 2023-03-06 | $2.00M 10-K · filed 2023-03-06 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.50M derived: sum of 2 quarters · filed 2022-11-07 | $2.00M 10-Q · filed 2022-11-07 | $2.35M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $2.00M 10-Q · filed 2022-08-08 | $2.35M derived: sum of 3 quarters · filed 2022-08-08 | $2.35M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $500.00K 10-Q · filed 2022-05-10 | $850.00K derived: sum of 2 quarters · filed 2022-05-10 | $850.00K derived: sum of 3 quarters · filed 2022-05-10 | |
| 2020-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $350.00K derived: sum of 2 quarters · filed 2022-03-15 | $1.94M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.58M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $1.58M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |